This case study describes the utilisation and continued development of a platform set up by UKHSA to support and encourage the research community to discover and develop new drugs against infectious diseases, including infections that are difficult to treat, through partnership with the ‘Pathways to Antimicrobial Clinical Efficacy’ (PACE) initiative